Research & Development

久久视频这里只精品思思热99re热在线视频人人超碰xxoo免费视频特斯拉全系8月底涨价在即 12月或迎新一波大涨


  王淼淼揉了揉發癢的鼻子︰“可能是昨天淋了雨,沒事,回去多喝點開水就好。”   “好甜。”草莓輕輕一咬便迸發出甜甜的汁水,此刻似乎比試吃的時候更甜了些,林徵羽一臉愉悅,揚起的嘴角帶著狡黠。久久视频这里只精品   過了半晌,他揉揉發澀的眼楮,確定自己不是在做夢。思思热99re热在线视频   “第一次見到你,說第一句話的時候。”林徵羽輕聲回答,頓了頓補充道︰“其實我就是我想吃年糕。”   安靜的環境中,陸昔年清楚的听到了兩人的對話。人人超碰xxoo免费视频

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo